DABIGATRAN Spirig HC caps 150 mg 60 pce

7680690550035 CH-69055 B01AE07 06.03.0.
DABIGATRAN Spirig HC caps 150 mg 60 pce
DABIGATRAN Spirig HC caps 150 mg 60 pce
DABIGATRAN Spirig HC caps 150 mg 60 pce
1 / 3
google

Details

Product number
6905502
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
dabigatranum etexilatum 150 mg ut dabigatrani etexilati mesilas, acidum tartaricum, acaciae gummi, hydroxypropylcellulosum, hypromellosum, talcum, dimeticonum 350, Kapselhülle: hypromellosum, kalii chloridum, carrageenanum, E 171, E 132, aqua purificata, pro capsula.

Articles (1)

Dabigatran Spirig HC 150 mg, Hartkapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2024
Patient information leaflet
Français
24/06/2024
Patient information leaflet
Italien
24/06/2024
Professional SmPC
Allemand
24/06/2024
Professional SmPC
Français
24/06/2024
Professional SmPC
Italien
24/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 60.95
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69055
Drug name
Dabigatran Spirig HC, Hartkapseln
Galenic form
KAHA
ATC Code
B01AE07
Authorization status
Z
Dispensation category
B
First authorization
11/12/2023
Authorization expiration date
10/12/2028
IT number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Packaging details

Description (FR)
DABIGATRAN Spirig HC caps 150 mg 60 pce
Description (DE)
DABIGATRAN Spirig HC Kaps 150 mg 60 Stk
Market launch
11/12/2023
Narcotic (BTM)
No

Original drug

Pradaxa, Kapseln
CHF 71.50
View original

Other packaging sizes

DABIGATRAN Spirig HC caps 110 mg 60 pce
60 KAP
View
DABIGATRAN Spirig HC caps 110 mg 180 pce
180 KAP
View
DABIGATRAN Spirig HC caps 150 mg 180 pce
180 KAP
View